Literature DB >> 16470080

Drug-induced metabolic syndrome.

Marion R Wofford1, Deborah S King, T Kristopher Harrell.   

Abstract

The metabolic syndrome is a cluster of risk factors associated with an increased risk for cardiovascular disease and type 2 diabetes. Based on data from 1988 to 1994, it is estimated that 24% of adults in the United States meet the criteria for diagnosis of the metabolic syndrome. The use of certain medications may increase the risk of the metabolic syndrome by either promoting weight gain or altering lipid or glucose metabolism. Health providers should recognize and understand the risk associated with certain medications and appropriately monitor for changes related to the metabolic syndrome. Careful attention to drug choices should be paid in patients who are overweight or have other risk factors for diabetes or cardiovascular disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16470080      PMCID: PMC8109499          DOI: 10.1111/j.1524-6175.2006.04751.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  37 in total

Review 1.  The metabolic impact of oral contraceptives.

Authors:  R M Krauss; R T Burkman
Journal:  Am J Obstet Gynecol       Date:  1992-10       Impact factor: 8.661

2.  Pancreatic beta cells are important targets for the diabetogenic effects of glucocorticoids.

Authors:  F Delaunay; A Khan; A Cintra; B Davani; Z C Ling; A Andersson; C G Ostenson; J Gustafsson; S Efendic; S Okret
Journal:  J Clin Invest       Date:  1997-10-15       Impact factor: 14.808

3.  H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs.

Authors:  Wesley K Kroeze; Sandra J Hufeisen; Beth A Popadak; Sean M Renock; SeAnna Steinberg; Paul Ernsberger; Karu Jayathilake; Herbert Y Meltzer; Bryan L Roth
Journal:  Neuropsychopharmacology       Date:  2003-03       Impact factor: 7.853

4.  Diuretics and beta-blockers do not have adverse effects at 1 year on plasma lipid and lipoprotein profiles in men with hypertension. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.

Authors:  M R Lakshman; D J Reda; B J Materson; W C Cushman; E D Freis
Journal:  Arch Intern Med       Date:  1999-03-22

Review 5.  Human growth hormone: a complex of proteins.

Authors:  U J Lewis; R N Singh; G F Tutwiler; M B Sigel; E F VanderLaan; W P VanderLaan
Journal:  Recent Prog Horm Res       Date:  1980

6.  Association between altered expression of adipogenic factor SREBP1 in lipoatrophic adipose tissue from HIV-1-infected patients and abnormal adipocyte differentiation and insulin resistance.

Authors:  Jean Philippe Bastard; Martine Caron; Hubert Vidal; Véronique Jan; Martine Auclair; Corinne Vigouroux; Jacqueline Luboinski; Martine Laville; Mustapha Maachi; Pierre Marie Girard; Willy Rozenbaum; Philippe Levan; Jacqueline Capeau
Journal:  Lancet       Date:  2002-03-23       Impact factor: 79.321

7.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  Hypertension       Date:  2003-12-01       Impact factor: 10.190

8.  Metabolic outcome during 1 year in newly detected hypertensives: results of the Antihypertensive Treatment and Lipid Profile in a North of Sweden Efficacy Evaluation (ALPINE study).

Authors:  Lars H Lindholm; Mats Persson; Petar Alaupovic; Bo Carlberg; Anders Svensson; Ola Samuelsson
Journal:  J Hypertens       Date:  2003-08       Impact factor: 4.844

9.  Antihypertensive drug therapy and the initiation of treatment for diabetes mellitus.

Authors:  J H Gurwitz; R L Bohn; R J Glynn; M Monane; H Mogun; J Avorn
Journal:  Ann Intern Med       Date:  1993-02-15       Impact factor: 25.391

10.  Nicotinic acid as therapy for dyslipidemia in non-insulin-dependent diabetes mellitus.

Authors:  A Garg; S M Grundy
Journal:  JAMA       Date:  1990-08-08       Impact factor: 56.272

View more
  11 in total

1.  The benefits of angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers combined with calcium channel blockers on metabolic, renal, and cardiovascular outcomes in hypertensive patients: a meta-analysis.

Authors:  Punnaka Pongpanich; Pasvich Pitakpaiboonkul; Kullaya Takkavatakarn; Kearkiat Praditpornsilpa; Somchai Eiam-Ong; Paweena Susantitaphong
Journal:  Int Urol Nephrol       Date:  2018-10-15       Impact factor: 2.370

2.  Susceptibility of male wild type mouse strains to antipsychotic-induced weight gain.

Authors:  Rizaldy C Zapata; Olivia Osborn
Journal:  Physiol Behav       Date:  2020-03-07

3.  The skin function: a factor of anti-metabolic syndrome.

Authors:  Shi-Sheng Zhou; Da Li; Yi-Ming Zhou; Ji-Min Cao
Journal:  Diabetol Metab Syndr       Date:  2012-04-26       Impact factor: 3.320

Review 4.  Animal models of metabolic syndrome: a review.

Authors:  Sok Kuan Wong; Kok-Yong Chin; Farihah Hj Suhaimi; Ahmad Fairus; Soelaiman Ima-Nirwana
Journal:  Nutr Metab (Lond)       Date:  2016-10-04       Impact factor: 4.169

5.  Secondary metabolic syndrome: the frequency of factors which may underlie the parameters of metabolic syndrome.

Authors:  Aytekin Oguz; Banu Mesci; Gul Sagun; Damla Coksert Kilic; Demet Ozgil Yetkin; Arzu Akalin
Journal:  Ann Saudi Med       Date:  2013 Nov-Dec       Impact factor: 1.526

6.  A phenotypic Caenorhabditis elegans screen identifies a selective suppressor of antipsychotic-induced hyperphagia.

Authors:  Anabel Perez-Gomez; Maria Carretero; Natalie Weber; Veronika Peterka; Alan To; Viktoriya Titova; Gregory Solis; Olivia Osborn; Michael Petrascheck
Journal:  Nat Commun       Date:  2018-12-10       Impact factor: 14.919

Review 7.  Metabolic syndrome and its associated factors in Ethiopia: A systematic review and meta-analysis.

Authors:  Tadeg Jemere; Belayneh Kefale
Journal:  J Diabetes Metab Disord       Date:  2021-05-09

8.  Conserved immunomodulatory transcriptional networks underlie antipsychotic-induced weight gain.

Authors:  Rizaldy C Zapata; Besma S Chaudry; Mariela Lopez Valencia; Dinghong Zhang; Scott A Ochsner; Neil J McKenna; Olivia Osborn
Journal:  Transl Psychiatry       Date:  2021-07-22       Impact factor: 6.222

9.  Association of benzodiazepines, opioids and tricyclic antidepressants use and falls in trauma patients: Conditional effect of age.

Authors:  Sergio Cordovilla-Guardia; Tania Bautista Molina; Cristina Franco-Antonio; Esperanza Santano-Mogena; Raquel Vilar-López
Journal:  PLoS One       Date:  2020-01-15       Impact factor: 3.240

10.  Metabolomic profiles associated with a mouse model of antipsychotic-induced food intake and weight gain.

Authors:  Rizaldy C Zapata; Sara Brin Rosenthal; Kathleen Fisch; Khoi Dao; Mohit Jain; Olivia Osborn
Journal:  Sci Rep       Date:  2020-10-29       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.